Cardio Diagnostics Inc. (CDIOW)
0.06
-0.01 (-11.11%)
At close: Feb 05, 2025, 2:58 PM
0.06
0.00%
After-hours Feb 05, 2025, 02:58 PM EST
undefined% (undefined)
| Bid | 0.05 |
| Market Cap | 18.74M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.06 |
| Volume | 11,419 |
| Avg. Volume (20D) | 0 |
| Open | 0.05 |
| Previous Close | 0.07 |
| Day's Range | 0.05 - 0.06 |
| 52-Week Range | 0.05 - 0.06 |
| Beta | undefined |
About CDIOW
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois....
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 7
Stock Exchange NASDAQ
Ticker Symbol CDIOW
Website https://cardiodiagnosticsinc.com